Your browser doesn't support javascript.
loading
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing.
Thibodeau, My Linh; O'Neill, Kieran; Dixon, Katherine; Reisle, Caralyn; Mungall, Karen L; Krzywinski, Martin; Shen, Yaoqing; Lim, Howard J; Cheng, Dean; Tse, Kane; Wong, Tina; Chuah, Eric; Fok, Alexandra; Sun, Sophie; Renouf, Daniel; Schaeffer, David F; Cremin, Carol; Chia, Stephen; Young, Sean; Pandoh, Pawan; Pleasance, Stephen; Pleasance, Erin; Mungall, Andrew J; Moore, Richard; Yip, Stephen; Karsan, Aly; Laskin, Janessa; Marra, Marco A; Schrader, Kasmintan A; Jones, Steven J M.
Afiliación
  • Thibodeau ML; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • O'Neill K; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Dixon K; Hereditary Cancer Program, BC Cancer, Vancouver, BC, Canada.
  • Reisle C; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Mungall KL; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Krzywinski M; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Shen Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Lim HJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Cheng D; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Tse K; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Wong T; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Chuah E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Fok A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Sun S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Renouf D; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Schaeffer DF; Hereditary Cancer Program, BC Cancer, Vancouver, BC, Canada.
  • Cremin C; Hereditary Cancer Program, BC Cancer, Vancouver, BC, Canada.
  • Chia S; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Young S; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Pandoh P; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Pleasance S; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Pleasance E; Hereditary Cancer Program, BC Cancer, Vancouver, BC, Canada.
  • Mungall AJ; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Moore R; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Yip S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Karsan A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Laskin J; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Schrader KA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Jones SJM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Genet Med ; 22(11): 1892-1897, 2020 11.
Article en En | MEDLINE | ID: mdl-32624572
ABSTRACT

PURPOSE:

Structural variants (SVs) may be an underestimated cause of hereditary cancer syndromes given the current limitations of short-read next-generation sequencing. Here we investigated the utility of long-read sequencing in resolving germline SVs in cancer susceptibility genes detected through short-read genome sequencing.

METHODS:

Known or suspected deleterious germline SVs were identified using Illumina genome sequencing across a cohort of 669 advanced cancer patients with paired tumor genome and transcriptome sequencing. Candidate SVs were subsequently assessed by Oxford Nanopore long-read sequencing.

RESULTS:

Nanopore sequencing confirmed eight simple pathogenic or likely pathogenic SVs, resolving three additional variants whose impact could not be fully elucidated through short-read sequencing. A recurrent sequencing artifact on chromosome 16p13 and one complex rearrangement on chromosome 5q35 were subsequently classified as likely benign, obviating the need for further clinical assessment. Variant configuration was further resolved in one case with a complex pathogenic rearrangement affecting TSC2.

CONCLUSION:

Our findings demonstrate that long-read sequencing can improve the validation, resolution, and classification of germline SVs. This has important implications for return of results, cascade carrier testing, cancer screening, and prophylactic interventions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2020 Tipo del documento: Article País de afiliación: Canadá